baber/WOPTO huggingface dataset:
Patent NZ-218453-A (NZ)
Title: Pharmaceutical compositions containing a synergistic mixture of a dihydropyridine derivative and pyridazodiazepine derivative
Inventor: GARTHOFF B
IPC: A61K31/55
Filed: 1986-12-01
Abstract: Compositions for treating hypertension comprising an effective amount of a dihydropyridine of the formula   <IMAGE>   in which X is 1 or 2 identical or different substituents from the group consisting of nitro, chlorine and trifluoromethyl, or together with the phenyl ring, the group   <IMAGE>  R1 is alkyl of 1 to 4 C atoms, which is optionally substituted by alkoxy of 1 to 4 C atoms, R2 is alkyl of 1 to 12 C atoms, which is optionally substituted by alkoxy of 1 to 3 C atoms, fluorine or N-methyl-N-benzylamino and R3 is alkyl of 1 to 4 C atoms, cyano or hydroxymethyl, and a pyridazodiazepine of the formula <IMAGE>   in which R4 is aralkyl, R5 is hydrogen or alkyl of 1 to 8 C atoms, R6 is hydrogen or alkyl of 1 to 8 C atoms and R7 and R8 are hydrogen, or together, an oxo group, are described.
Patent NZ-222483-A (NZ)
Title: Roof extractor fan with centrifugally operated non return shutter
Inventor: WHEELER J
IPC: F16K17/04
Filed: 1987-11-09
Abstract: A powered, direct discharge ventilator comprises an extraction fan (K) having a fan duct (12) and a self weathering, non-return shutter plate (P) for closing the exit from the extraction fan duct (12) when the ventilator is not operating. The shutter plate (12) is guided by rods (21) to be opened by the airstream when the fan (K) is started, whilst maintaining a position generally parallel to that which it occupies in its fan duct closing position and to be closed by springs (23) when the fan (K) is stopped. The fan (K) mounts a centrifugally operable latch (30), co-incident with its rotational axis (C), and the shutter plate (P) carries a catch (31) to be engaged by the latch (30) when the shutter plate (P) is closed, the catch then preventing lifting of the shutter plate (P) due to "wind-over" effect when the fan (K) is stationary. When the fan (K) is started, the catch (30) is centrifugally operated to release the catch (31) to allow the shutter plate (P) to open.
Patent NZ-227069-A (NZ)
Title: Laminate of stretch wrapping film with flat reinforcing band
Inventor: PARRY JOHN C
IPC: B65D65/40
Filed: 1988-11-24
Abstract: Stretch wrapping film is reinforced by means of an auxiliary band that is laminated to the stretch film, thereby obtaining improved effective film strength without requiring the use of heavy duty films. Propagating tears that do occur are arrested by the band. The band may be rendered visually distinctive by coloration or imprinting, to identify the load with which it is wrapped, and to enable one to locate the leading edge of the film on the roll.
Patent NZ-229320-A (NZ)
Title: Plasma treatment of tube inside wall
Inventor: MONTGOMERY DAVID B
IPC: A61F2/06
Filed: 1989-05-29
Abstract: An apparatus for generating a plasma in the lumen of a small diameter tube includes a housing (12) having a diaphragm (18) which separates the housing into a first chamber (14) equipped with a gas inbleed (26) assembly and a second chamber (16) connected to a vacuum source. Parallel plate electrodes (58) in the first chamber are encased in a dielectric (42) which prevents substantially all plasma discharge external of a plasma zone between the electrodes. A conduit (64) maintains gas flow between the chambers. A bore (52) through the dielectric includes the plasma zone and receives the tube (54) to be plasma treated. A method for treating the luminal wall of a plastic tube (54) includes positioning a tube in the plasma zone, evacuating the chambers, bleeding a gas into the chambers, and delivering radiofrequency power to the electrodes (58). A long tube may be drawn through the plasma zone, or the dielectric and electrodes may be moved past the tube.
Patent NZ-242192-A (NZ)
Title: Inhibiting pulmonary toxicity using antibodies capable of binding icam-1
Inventor: WEGNER CRAIG DONALD
IPC: A61K38/00
Filed: 1992-04-01
Abstract: A method for inhibiting pulmonary oxygen toxicity in a patient requiring elevated levels of inhaled oxygen, by prophylactic administration of certain adhesion molecules and antibodies thereto.
Patent NZ-246087-A (NZ)
Title: Production of optically active norborneol from a racemic ester mixture using a microoganism or treated cells thereof
Inventor: BUNJI KAGEYAMA
IPC: C12P41/00
Filed: 1992-12-04
Abstract: A process for producing optically active norborneol comprising the step of bringing a (+/-)-exo-norbornane type ester represented by formula (I) into contact with a microorganism, which may be optionally treated, selected from among those belonging to the genera Pseudomonas, Acetobacter, Arthrobacter, Rhodotorula and Saccharomyces. A simple post-treatment of the product gives rise to highly pure (+)- and/or (-)-exo-norbornane type alcohol in high yields.
Patent NZ-247291-A (NZ)
Title: Subcutaneous implantation device for medicinal implants
Inventor: WIEGERINCK MAARTEN ANTONIUS HE
IPC: G01N/
Filed: 1993-03-30
Abstract: The invention relates to an implantation device with which a medicinal implant can be introduced subcutaneously in humans or animals. Said device comprises a hollow needle and a mandrel having a chamfered distal end, which precisely coincides with the plane of the chamfered distal end of the hollow needle.
Patent NZ-247514-A (NZ)
Title: Benzyl enol ether derivatives, preparation and pesticidal compositions thereof
Inventor: WINGERT HORST
IPC: C07C255/54
Filed: 1993-04-28
Abstract: Benzyl enol ether derivatives of the formula I <IMAGE>  in which   A denotes CH2, CHCl, CH-alkyl, CH-O-alkyl, CH-S-alkyl, N-O-alkyl and     B denotes OH, alkoxy, alkylthio and alkylamino, U, V and W are identical or different and denote hydrogen, halogen, alkyl and alkoxy, R<1>, R<2> and R<3> are identical or different and denote hydrogen, cyano, halogen, amino, ester, amide, acyl, S(O)nR<4>, PO(OR<4>)2, alkyl, haloalkyl, cycloalkyl, halocycloalkyl, cycloalkyl-alkyl, alkoxy-alkyl, alkylthio-alkyl, arylthio-alkyl, alkenyl, haloalkenyl, cycloalkenyl, halocycloalkenyl, alkynyl, alkoxy, haloalkoxy, alkylthio, benzylthio, alkylcarbonyl, optionally substituted phenylcarbonyl, optionally substituted benzylcarbonyl, alkoxycarbonyl, optionally substituted phenoxycarbonyl, optionally substituted benzyloxycarbonyl, optionally substituted aryl, optionally substituted aryloxy, optionally substituted arylthio, optionally substituted arylalkyl, optionally substituted arylalkenyl, optionally substituted aryloxyalkyl, optionally substituted arylthioalkyl, optionally substituted hetaryl, optionally substituted hetaryloxy, optionally substituted hetarylthio, optionally substituted heteroarylalkyl, optionally substituted hetarylalkenyl, optionally substituted hetaryloxyalkyl, optionally substituted heterocyclyl and optionally substituted heterocyclyloxy, and   the radical R<4> denotes hydrogen and C1-C4-alkyl, and R<1> and R<3> together and also R<2> and R<3> together can in each case form a carbocyclic or heterocyclic ring which, in turn, can be benzo-fused and substituted, and fungicides containing these compounds.
Patent NZ-301499-A (NZ)
Title: A knitted footlet having a thickened cushion area in the ball portion area thereof
Inventor: THRONEBURG JAMES L
IPC: A41B11/10
Filed: 1996-01-11
Abstract: A foot protector in combination with hosiery, such as high fashion women's hosiery, is provided to be worn on a foot of a wearer. The foot protector is designed and constructed to provide cushioning comfort to a ball portion, i.e., bottom or planar areas thereof, of a wearer's foot to concentrate cushioning to where most needed. The foot protector preferably is a knit footlet having integrally knit thickened cushion areas provided only in ball portion areas thereof, whereby other areas of the footlet are not thickened to such an amount as to make a shoe feel undersized and tight on a wearer's foot. The knit thickened cushion areas have terry loops integrally knit only in a ball portion of the footlet and are so constructed as to underlie only a corresponding ball portion of a wearer's foot. A method of forming a foot protector arranged to be positioned over a wearer's foot is also provided which includes knitting at least one body yarn to form at least heel, arch, ball and toe portions and define a footlet and integrally knitting terry loops with the one body yarn only in the ball portion of the footlet. A method of wearing a foot protector over a wearer's foot and underneath other hosiery is further provided and includes positioning knit thickened cushion areas of terry loops integrally knit only in ball portion areas of a footlet so as to underlie and intimately contact only a ball portion of a wearer's foot.
Patent NZ-502946-A (NZ)
Title: Tyrosine kinase containing Ig and EGF homology domains (TIE) ligands and nucleic acid molecules encoding them
Inventor: GURNEY AUSTIN L
IPC: C07K14/435
Filed: 1998-09-14
Abstract: Isolated nucleic acid molecules encoding the TIE ligands NL1, NL5, NL8, and NL4, the proteins encoded by such nucleic acid molecules, as well as methods and means for making and using such nucleic acid and protein molecules. Wherein; Seq ID 2 (NL1): MRPLCVTCWWLGLLAAMGAVAGQEDGFEGTEEGSPREFIYLNRYKR AGESQDKCTYTFIVPQQRVTGAICVNSKEPEVLLENRVHKQELELL NNELLKQKRQIETLQQLVEVDGGIVSEVKLLRKESRNMNSRVTQLYM QLLHEIIRKRDNALELSQLENRILNQTADMLQLASKYKDLEHKYQHL ATLAHNQSEIIAQLEEHCQRVPSARPVPQPPPAAPPRVYQPPTYNRIIN QISTNEIQSDQNLKVLPPPLPTMPTLTSLPSSTDKPSGPWRDCLQAL EDGHDTSSIYLVKPENTNRLMQVWCDQRHDPGGWTVIQRRLDGSV NFFRNWETYKQGFGNIDGEYWLGLENIYWLTNQGNYKLLVTMEDWS GRKVFAEYASFRLEPESEYYKLRLGRYHGNAGDSFTWHNGKQFTTLDR DHDVYTGNCAHYQKGGWWYNACAHSNLNGVWYRGGHYRSRYQDGV YWAEFRGGSYSLKKVVMMIRPNPNTFH  Seq ID 4 (NL5): MKTFTWTLGVLFFLLVDTGHCRGGQFKIKKINQRRYPRATDGKEEAKKC AYTFLVPEQRITGPICVNTKGQDASTIKDMITRMDLENLKDVLSRQKREID VLQLVVDVDGNIVNEVKLLRKESRNMNSRVTQLYMQLLHEIIRKRDN SLELSQLENKILNVTTEMLKMATRYRELEVKYASLTDLVNNQSVMITL LEEQCLRIFSRQDTHVSPPLVQVVPQHIPNSQQYTPGLLGGNEI QRDPGYPRDLMPPPDLATSPTKSPFKIPPVTFINEGPFK DCQQAKEAGHSVSGIYMIKPENSNGPMQLWCENSLDPGGWTVIQKRTDGSV NFFRNWENYKKGFGNIDGEYWLGLENIYMLSNQDNYKLLIELEDW SDKKVYAEYSSFRLEPESEFYRLRLGTYQGNAGDSMMWHNG KQFTTLDRDKDMYAGNCAHFHKGGWWYNACAHSNLNGVWYRGGH YRSKHQDGIFWAEYRGGSYSLRAVQMMIKPID  Seq ID 6 (NL8): MGKPWLRALQLLLLLGASWARAGAPRCTYTFVLPPQKFTGAVC WSGPASTRATPEAANASELAALRMRVGRHEELLRELQRLAAADGA  VAGEVRALRKESRGLSARLGQLRAQLQHEAGPGAGPGA DLGAEPAAALALLGERVLNASAEAQRAAARFHQLDVKFRELAQLV TQQSSLIARLERLCPGGAGGQQQVLPPPPLVPVVPVRLVGST SDTSRMLDPAPEPQRDQTQRQQEPMASPMPAGHPAVPTKPVGPWQDCAEA RQAGHEQSGVYELRVGRHVVSVWCEQQLEGGGWTVIQRRQDGSVN FFTTWQHYKAGFGRPDGEYWLGLEPVYQLTSRGDHELLVLLEDWGGR GARAHYDGFSLEPESDHYRLRLGQYHGDAGDSLSWHNDKPFS TVDRDRDSYSGNCALYQRGGWWYHACAHSNLNGVWHHGGH YRSRYQDGVYWAEFRGGAYSLRKAAMLIRPLKL  Seq ID 19 (NL4): MLKKPLSAVTWLCIFIVAFVSHPAWLQKLSKHKTPAQPQLKAANCC EEVKELKAQVANLSSLLSELNKKQERDWVSVVMQVMELESNSK RMESRLTDAESKYSEMNNQIDIMQLQAAQTVTQTSADAIYDCSSLY QKNYRISGVYKLPPDDFLGSPELEVFCDMETSGGGWTIIQRRKSGLV SFYRDWKQYKQGFGSIRGDFWLGNEHIHRLSRQPTRLRVEME DWEGNLRYAEYSHFVLGNELNSYRLFLGNYTGNVGNDALQYHNNTAFST KDKDNDNCLDKCAQLRKGGYWYNCCTDSNLNGVYYRLGEHNK HLDGITWYGWHGSTYSLKRVEMKIRPEDFKP
Patent NZ-503506-A (NZ)
Title: Secure network transaction system having gatekeeper coupled to the network which receives and authenticates authorisation signals from communication terminals
Inventor: KHAN TARIQ M
IPC: G06Q20/02
Filed: 1998-09-03
Abstract: A system for performing regulated transactions is used with a network (104) that is commonly accessible by a plurality of communication terminals (102). A gatekeeper (108), coupled to the network (104), permits access to the system only if authorization information, as indicated by an authorization signal received by the gatekeeper (108) from a communication terminal via the network (104), complies with at least one predetermined criterion. The authorization information includes information independent of information supplied by a communication terminal user and independent of information indicative of a communication line coupled to the user's communication terminal. A host (110), coupled to the gatekeeper (108), receives a first signal from the user's communication terminal through the network (104) and sends a second signal through the network to the user's communication terminal in response to the first signal.
Patent NZ-504483-A (NZ)
Title: High throughput method for functionally classifying proteins by contacting the protein with different molecules and determining the effect on the proteins stability
Inventor: PETRELLA EUGENIO C
IPC: C40B30/04
Filed: 1998-11-12
Abstract: Described is a method for functionally classifying a protein that is capable of unfolding due to a thermal change.  The method comprises screening one or more of a multiplicity of different molecules for their ability to shift the thermal unfolding curve of the protein, wherein a shift in the thermal unfolding curve indicates that the molecule binds to the protein or affects the stability in a measurable way; generating an activity spectrum for the protein wherein the activity spectrum reflects a set of molecules, from the multiplicity of molecules, that shift the thermal unfolding curve, of the protein and therefore are ligands that bind to the protein, comparing the activity spectrum for the protein to one or more functional reference spectrum lists; and classifying the protein according to the set of molecules in the multiplicity of different molecules that shift the thermal unfolding curve of the protein.
Patent NZ-506954-A (NZ)
Title: Process for the preparation of methyl(2s)-2-[(3r)-3-(n-[tert-butyloxycarbonyl]-amino)-2-oxopyrrolidin-1-yl]propionate
Inventor: PATEL IAN
IPC: C07K5/078
Filed: 1999-04-27
Abstract: A chemical process for the manufacture of methyl (2S)-2-[3R)-3-(N-[tert-butyloxycarbonyl]amino)-2-oxopyrrolidin-1-yl]propionate of the formula (I).
Patent NZ-510944-A (NZ)
Title: Orthopedic bed aide
Inventor: BATT PAUL THOMAS ALEXANDER
IPC: A47C20/02
Filed: 2001-04-04
Abstract: An orthopedic bed aide comprising of foam pads and blocks that can be used in pairs or individually for the correct support of a patient, is disclosed.   The set of foam pads comprises of a rubber back pad for raising the patient who needs constant turning in bed, a foot pad for raising the patients feet and a foot block for the patient to rest or push their feet against to make themselves more comfortable or help them get out of bed. The set of natural foam rubber back pads for raising the patients back has two widths, 92cm for a single bed and 86cm for a double bed.  The raised angles from the horizontal of the back pads are 33 degrees, 40 degrees and 45 degrees.  The foot pad for raising the patients feet has two widths, 92cm for a single bed and 86cm for a double bed and are raised from the horizontal by 25 degrees and 30 degrees.   The foot block is in the form of a T-shaped pad.  The foot block is made from a hard foam rubber with two soft foam rubber pads on either side of the T for the patients to rest their feet on or against.  The hard rubber in the middle of the T is for the patient to push on with a foot to help them get out of bed without using their hands.  The foot block comes in one width of 86cm.  The back and foot pads can be made out of firm airtight plastic with an air valve for portable or military use.
Patent NZ-511087-A (NZ)
Title: Human orphan G protein-coupled receptors
Inventor: CHEN RUOPING
IPC: C12N/
Filed: 1999-10-13
Abstract: An isolated polynucleotide encoding a G protein-coupled receptor is disclosed. Also covered is a vector containing said polynucleotide, the polypeptide encoded by said polynucleotide, host cells transfected with said polynucleotide, membranes of said transfected host cells, and the use of the polynucleotide or polypeptide in the preparation of a medicament for modulating glucose and insulin concentration in the blood of a mammal.
Patent NZ-514846-A (NZ)
Title: RT-PCR of clonal neurospheres
Inventor: SUSLOV OLEG N
IPC: C12N15/10
Filed: 2000-03-17
Abstract: A method is described for the preparation, characterization and utilization of temporally ordered panels of cDNA libraries from human microclones. Each microclone undergoing morphogenetic differentiation in vitro differs in discrete gene expression. The developmental stage of the microclone is determined and the gene expression patterns of the microclones temporally ordered and arranged into expression profiles and temporal spectra. Direct comparison of the cDNAs produced from different neural microclones allows identification of novel RNA transcripts.
Patent NZ-519264-A (NZ)
Title: Thiazolidinedione derivatives that display high hypoglycaemic activity and are used in the treatment of diabetes, hyperglycaemia and hyperlipidaemia
Inventor: MOURELLE MANCINI MARISABEL
IPC: A61K31/506
Filed: 2000-11-15
Abstract: Described are compounds of the general formula (I), their possible pharmaceutically acceptable salts and tautomeric forms. R1 is: H or C1-C6 alkyl; R2: H, C1-C6 alkyl, halogen (F, Cl, Br, I), OR5, SR5, NR5R6, NO2, or phenyl; R3: H, C1-C6 alkyl, halogen (F, Cl, Br, I), OR5, SR5, NR5R6, NO2, or phenyl; R4: H, C1-C6 alkyl, halogen (F, Cl, Br, I), OR5, NR5R6, phenyl, or R3 and R4 when taken together, are -CH=CH-CH=CH- forming a fused ring on the pyrimidine ring. R5, R6 are independent to each other, and they may be H or C1-C6 alkyl, R7: H or NH2, R8: H, C1-C6 alkyl, to their possible pharmaceutically acceptable salts and tautomeric forms. The present invention also refers to a process for their production and to their use as antidiabetic and hypoglycaemic agents, alone or in combination with other antidiabetic agents, such as sulfonylurea's or biguanides, as well as for the treatment of complications associated to the resistance to the insulin, such as hypertension, hyperuricemia or other cardiovascular, metabolic and endocrine conditions, etc. The preferred compounds of the present invention are those in which: R1: CH3; R2: H, OR5, NR5R6; R3: H, halogen (F, Cl, Br, I), OR5; R4: H or wherein R3 and R4 are as defined previously. Described is also process for their production and their use as antidiabetic and hypoglycaemic agents, alone or in combination with other antidiabetic agents, such as sulfonylurea's or iguanids. In addition their use in the treatment of complications associated to the resistance to the insulin, such as hypertension, hyperuricemia or other cardiovascular, metabolic, endocrine conditions, or other conditions related with diabetes is disclosed.
Patent NZ-520832-A (NZ)
Title: Wagering golf game where players have a scorecard to predict the score anticipated for each hole
Inventor: BENNETT NICHOLAS LUKE
IPC: A63F9/00
Filed: 2001-03-07
Abstract: A wagering game includes a plurality of tokens, each token carrying an indicium representative of a particular score in a predetermined game. The game further includes a plurality of scorecards, one for each participant in the game. At least one scorecard is issued to each participant in the game. Each scorecard includes entered information relating to a feature of the game so that, when a token is presented by a caller of the game, each participant having information on that participant's scorecard corresponding to the indicium can mark an appropriate part of the scorecard. The number of presented tokens carrying indicia, which match the entered information on the scorecard of the participant, if any, awarded to the participant governs a prize.
Patent NZ-522535-A (NZ)
Title: Preparation of cyclohexene carboxylate derivatives
Inventor: KENT KENNETH M
IPC: C07C67/333
Filed: 1997-08-22
Abstract: A process for preparing compounds of the formula 5 comprises reacting a compound of formula 4 with a dehydrating reagent. A process for preparing compounds of formula 11 comprises reacting a compound of formula 10 with a Lewis acid reagent. A process for preparing compounds of formula 31 comprises reacting a compound of formula 30 with a reducing reagent. A process for preparing compounds of formula 41 comprises reacting a compound of formula 40 with an amine reagent. A process for preparing compounds of formula 71 comprises reacting a compound of formula 61 with an oxidizing reagent. A cyclohexene derivative or a salt, solvate or enantiomer thereof has the formula 40 wherein R2, R4, R20 and R21 are as defined below. In the above formulae: R1 is a cyclic hydroxy protecting group; R2 is a carboxylic acid protecting group; R3 is a hydroxy protecting group; R7 is H or an amino protecting group; each R20 is independently H or alkyl; R4 is -C(R30)3; R5 is H or R3; each R21 is independently R20, Br, Cl, F, I, CN, NO2 or N3; each R30 is independently H, R24, W or R24aW; and W is optionally substituted carbocyclic or heterocycle R31 is a ketal or acetal; R24, R24a are as defined above and Y1 is a mono-, di- or unsubstituted amino group.
Patent NZ-524369-A (NZ)
Title: Improvements relating to frequency estimation
Inventor: SCOTT IAN RUSSELL
IPC: H04L27/233
Filed: 2003-02-24
Abstract: A method for estimating the frequency offset of a signal includes: obtaining samples of the signal at least two instants in time, and utilising the samples in a mathematical equation relating the estimated offset frequency to the samples, wherein the mathematical equation is derived based on the premise of a modulating signal with a complex frequency.
Patent NZ-527435-A (NZ)
Title: Transgenic animals produced by homologous sequence targeting
Inventor: PATI SUSHMA
IPC: A01K67/027
Filed: 1999-05-14
Abstract: A method for producing a transgenic non-human mammal comprising a modified pre-selected endogenous wild-type sequence is disclosed, wherein the method comprises: a) Introducing into a zygote a composition comprising a recombinase and a first and a second single-stranded substantially complementary targeting polynucleotide each having a homology clamp substantially corresponding to or substantially complementary to a pre-selected wild-type target DNA sequence, wherein said pre-selected wild-type target DNA sequence is modified by homologous recombination with at least one of said first or second substantially complementary targeting polynucleotides, and wherein the modification is selected from the group consisting of a substitution, insertion and deletion of at least one nucleotide in said pre-selected wild-type target DNA sequence, and wherein the pre-selected wild-type target sequence encodes for an ion-channel, a G-protein coupled receptor (GPCR), an immunoglobin, a growth factor, an enzyme, or a milk protein; and b) Generating said transgenic non-human mammal from said zygote. The transgenic non-human mammals produced include cattle, sheep, pigs, horses, goats and non-human primates. (62) Divided out of 508665
Patent NZ-527695-A (NZ)
Title: GlyT-1 inhibitors
Inventor: EGLE IAN
IPC: C07D409/00
Filed: 2002-02-15
Abstract: A compound of formula (I), wherein Ar1 is a thiophene group which may be 2 or 3 thiophene and is optionally substituted with up to one substituent selected from methyl or ethyl; Ar2 is selected from thiophene, furan and substituted phenyl, wherein the substituent on the phenyl group is selected from C1-6 alkyl, halo, C1-6 haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, cyano and a salt, solvate and hydrate thereof.
Patent NZ-531984-A (NZ)
Title: Automatic inflator with status indicator
Inventor: MACKAL GLENN H
IPC: B63C9/15
Filed: 2002-09-04
Abstract: An automatic inflator is disclosed having a status indicator that indicates whether a fully-charged, unspent gas cylinder has been install ed to the automatic inflator, whether a fully-operable bobbin has been properly installed within the automatic inflator and whether the threaded cap of the automatic inflator has been fully installed, comprising an indicator window that displays the color "green" when the automatic inflator is fully operational automatically or the color "red" when the automatic inflator is at least partially inoperable automatically due to the removal of the gas cylinder, due to at least partial removal of the threaded cap, or due to the firing of the inflator resulting in a spent bobbin or gas cylinder .